John M. Inadomi

University of Utah — United States

Medicine · Health Sciences

66h-index19.2kcitations503works7.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Colorectal Cancer Screening and Detection(145), Gastric Cancer Management and Outcomes(125), Esophageal Cancer Research and Treatment(124), Esophageal and GI Pathology(91), Gastroesophageal reflux and treatments(79)

Publications502 total

<scp>GLP</scp> ‐1 receptor agonists for treating obesity without diabetes: A systematic review and meta‐analysis of economic evaluations
Diabetes Obesity and Metabolism·2025· 1 citedOpen Access
Author response for "GLP-1 receptor agonists for treating obesity without diabetes: a systematic review and meta-analysis of economic evaluations"
2025
AGA Clinical Practice Guideline on Surveillance of Barrett’s Esophagus
Gastroenterology·2025· 4 cited
S631 Comparative Efficacy of Multilevel Interventions for Increasing Colorectal Cancer Screening Uptake: A Network Meta-Analysis
The American Journal of Gastroenterology·2025
268. COST-EFFECTIVENESS OF SCREENING FOR BARRETT’S ESOPHAGUS WITH ESOCHECK/ESOGUARD COMPARED TO SCREENING WITH UPPER ENDOSCOPY
Diseases of the Esophagus·2025Open Access
265. THE COST-EFFECTIVENESS OF RISK-BASED MANAGEMENT OF BARRETT’S ESOPHAGUS PATIENTS USING TISSUECYPHER OR P53 BIOMARKERS: A MICROSIMULATION STUDY
Diseases of the Esophagus·2025Open Access
Endoscopic Surveillance for Nondysplastic Barrett’s Esophagus: Are We Violating “Primum Non Nocere”?
Gastroenterology·2025· 1 citedOpen Access
Feasible and acceptable social drivers of health screening among patients with chronic liver disease
Hepatology Communications·2025Open Access
Benefits of colorectal cancer screening using fecal immunochemical testing with varying positivity thresholds by age and sex
JNCI Journal of the National Cancer Institute·2025· 2 citedOpen Access
462: BENEFITS OF PERSONALIZED COLORECTAL CANCER SCREENING USING FIT WITH VARYING POSITIVITY THRESHOLDS BY AGE AND SEX
Gastroenterology·2025
Sa1092: COST-EFFECTIVENESS OF SCREENING FOR BARRETT’S ESOPHAGUS WITH ESOCHECK/ESOGUARD COMPARED TO SCREENING WITH UPPER ENDOSCOPY
Gastroenterology·2025
Sa1089: THE COST-EFFECTIVENESS OF RISK-BASED MANAGEMENT OF BARRETT’S ESOPHAGUS PATIENTS USING TISSUECYPHER OR P53 BIOMARKERS: A MICROSIMULATION STUDY
Gastroenterology·2025
Abstract 2319: Anti-diabetes medication use and risk of colorectal polyps: a colonoscopy-based study using natural language processing
Cancer Research·2025
Response to Hu, Yang, and Sun
JNCI Journal of the National Cancer Institute·2024Open Access
Characteristics of a cost-effective blood test for colorectal cancer screening
JNCI Journal of the National Cancer Institute·2024· 22 citedOpen Access
AGA Clinical Practice Guideline on Endoscopic Eradication Therapy of Barrett’s Esophagus and Related Neoplasia
Gastroenterology·2024· 55 citedOpen Access
906 CMS COVERAGE DECISION: IMPLICATIONS FOR COST-EFFECITVENESS OF BLOOD-BASED COLORECTAL CANCER SCREENING
Gastroenterology·2024
908 CHARACTERISTICS OF A COST-EFFECTIVE BLOOD TEST FOR COLORECTAL CANCER SCREENING
Gastroenterology·2024· 1 cited
Presentation of the Julius M. Friedenwald Medal to M. Bishr Omary
Gastroenterology·2024Open Access
Screening for social determinants of health among populations at risk for MASLD: a scoping review
Frontiers in Public Health·2024· 14 citedOpen Access
page 1 of 26Next →

Frequent Co-authors

Yngve Falck–Ytter(8), Joel H. Rubenstein(6), Nicholas J. Shaheen(5), Sachin Wani(4), A. Mark Fendrick(4), Sandeep Vijan(4), Ma Somsouk(4), Philip Schoenfeld(4), Seth D. Crockett(3), Joseph D. Feuerstein(3), Siddharth Singh(3), Shahnaz Sultan(3), David A. Lieberman(3), Michael Vieth(3), Nimish Vakil(3), Richard E. Sampliner(3), Kenneth T. Wang(3), Alison T. Brenner(3), Henry D. Appelman(3), James M. Scheiman(3)